FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates
- September 25th, 2023
- 306 views
Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment, FemaSeed. This innovative solution is designed to deliver sperm directly to the fallopian tube, targeting the site of conception in women.
$FEMY was trading at $0.97 in the extended session, up $0.63 (+192.52%)
In other news, THOR Industries, Inc. (NYSE: THO), a leading recreational vehicle manufacturer, reported fourth-quarter fiscal 2023 earnings of $1.68 per share, surpassing the consensus EPS estimate of $0.96. The company's quarterly sales reached $2.74 billion, beating analysts' revenue projection of $2.42 billion.
Additionally, THOR Industries has provided guidance for full-year fiscal 2024, with expected diluted EPS in the range of $6.25 to $7.25, compared to the consensus EPS estimate of $7.12 for the period.
$THO was trading at $93.66 in after-hours, down $1.16 (-1.22%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login